Pfister; Jurg R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pfister; Jurg R..The latest application filed is for "treprostinil derivative compounds and methods of using same".

Company Profile

0.26.24

Pfister; Jurg R. - South San Francisco CA
Pfister; Jurg R. - Los Altos CA
PFISTER; Jurg R. - Sunnyvale CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treprostinil derivative compounds and methods of using same Grant 9,845,305 - Becker , et al. December 19, 2	2017-12-19
Treprostinil Derivative Compounds And Methods Of Using Same App 20170081303 - BECKER; Cyrus K. ; et al.	2017-03-23
Treprostinil derivative compounds and methods of using same Grant 9,505,737 - Becker , et al. November 29, 2	2016-11-29
7-azoniabicyclo[2.2.1]heptane Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20160296497 - PFISTER; Jurg R. ; et al.	2016-10-13
Treprostinil derivative compounds and methods of using same Grant 9,371,264 - Becker , et al. June 21, 2	2016-06-21
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof Grant 9,320,731 - Pfister , et al. April 26, 2	2016-04-26
Treprostinil Derivative Compounds And Methods Of Using Same App 20150166503 - BECKER; Cyrus K. ; et al.	2015-06-18
Treprostinil Derivative Compounds And Methods Of Using Same App 20140256730 - BECKER; Cyrus K. ; et al.	2014-09-11
7-azoniabicyclo[2.2.1]heptane Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20140249195 - PFISTER; Jurg R. ; et al.	2014-09-04
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof Grant 8,742,134 - Pfister , et al. June 3, 2	2014-06-03
7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof Grant 8,742,131 - Pfister , et al. June 3, 2	2014-06-03
7-azoniabicyclo[2.2.1]heptane Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20130157989 - Pfister; Jurg R. ; et al.	2013-06-20
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof Grant 8,426,611 - Pfister , et al. April 23, 2	2013-04-23
7-azoniabicyclo [2.2.1] Heptane Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20130059898 - Pfister; Jurg R. ; et al.	2013-03-07
4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof Grant 8,114,891 - Pfister , et al. February 14, 2	2012-02-14
7-azoniabicyclo[2.2.1]heptane Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20120029044 - Pfister; Jurg R. ; et al.	2012-02-02
4-substituted Quinuclidine Derivatives, Methods Of Production, And Pharmaceutical Uses Thereof App 20090088418 - Pfister; Jurg R. ; et al.	2009-04-02
5-HT3 receptor antagonists and methods of use Grant 7,501,436 - Zhang , et al. March 10, 2	2009-03-10
Materials and Methods for Treating Coagulation Disorders App 20080221204 - Druzgala; Pascal ; et al.	2008-09-11
Materials and methods for treating hypercholesterolemia Grant 7,384,973 - Druzgala , et al. June 10, 2	2008-06-10
Materials and Methods for Treating Hypercholesterolemia App 20080132561 - Druzgala; Pascal ; et al.	2008-06-05
Novel 5-HT3 Receptor Antagonists and Methods of Use App 20070197580 - Zhang; Xiaoming ; et al.	2007-08-23
Materials And Methods For Treating Coagulation Disorders App 20070129429 - Druzgala; Pascal ; et al.	2007-06-07
5-HT3 receptor antagonists and methods of use Grant 7,125,886 - Zhang , et al. October 24, 2	2006-10-24
Materials and methods for treating hypercholesterolemia App 20060116418 - Druzgala; Pascal ; et al.	2006-06-01
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis Grant 7,022,722 - Druzgala , et al. April 4, 2	2006-04-04
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20060047000 - Druzgala; Pascal ; et al.	2006-03-02
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis Grant 6,958,355 - Druzgala , et al. October 25, 2	2005-10-25
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20050075379 - Druzgala, Pascal ; et al.	2005-04-07
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20050037997 - Druzgala, Pascal ; et al.	2005-02-17
Novel 5-HT3 receptor antagonists and methods of use App 20040220246 - Zhang, Xiaoming ; et al.	2004-11-04
Materials and methods for treating coagulation disorders App 20040220258 - Druzgala, Pascal ; et al.	2004-11-04
5-HT3 receptor antagonists and methods of use Grant 6,770,655 - Zhang , et al. August 3, 2	2004-08-03
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis Grant 6,768,008 - Druzgala , et al. July 27, 2	2004-07-27
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis Grant 6,680,387 - Druzgala , et al. January 20, 2	2004-01-20
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20030236227 - Druzgala, Pascal ; et al.	2003-12-25
Novel 5-HT3 receptor antagonists and methods of use App 20030158221 - Zhang, Xiaming ; et al.	2003-08-21
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20030064972 - Druzgala, Pascal ; et al.	2003-04-03
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis App 20030027798 - Druzgala, Pascal ; et al.	2003-02-06
N.sup.6 mono heterocyclic substituted adenosine derivatives Grant 5,789,416 - Lum , et al. August 4, 1	1998-08-04
A1 adenosine receptor agonists and antagonists Grant 5,668,139 - Belardinelli , et al. September 16, 1	1997-09-16
10,11-Methanodibenzosuberane derivatives Grant 5,643,909 - Pfister , et al. July 1, 1	1997-07-01
N-aryloxyalkyl tryptamine .alpha..sub.1 -adrenergic receptor antagonists Grant 5,436,264 - Pfister , et al. July 25, 1	1995-07-25
+2-[(3,4-Methylenedioxy)phenethyl]-5-[(3-carboxamido-4-hy droxy)-.alpha.-hydroxybenzyl]pyrrolidines Grant 4,548,949 - Muchowski , et al. October 22, 1	1985-10-22
Anticholinergic bronchodilators Grant 4,353,922 - Pfister October 12, 1	1982-10-12
Thioxanthone carboxylic acids and derivatives Grant 3,904,647 - Pfister , et al. September 9, 1	1975-09-09
Alkenyl And Alkynyl Substituted Xanthone Carboxylic Acid Compounds Grant 3,818,040 - Pfister , et al. June 18, 1	1974-06-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.